The scope of the Computational Biology (CB) PIC is basic biomedical research at the interface of information technology and biology. This research is conducted often in collaboration with partners in universities, medical research centers, biotechnology companies and the pharmaceutical and health care industry. This PIC aims to impact the following strategic areas for the industry:

• Understand biological systems based on approaches derived from computer science, physics, mathematics, chemistry, and biology, supported by our expertise in these areas, and our unique position as leaders in information technology and high performance computing.
• Translate basic biomedical research into improved clinical care and prevention. In particular, focus on specific diseases affecting large sections of the population, such as cancer, infectious diseases, cardiovascular disease and psychiatric dysfunctions.
• Based on our strengths and collaborations, develop new, more effective, treatments, drugs, diagnosis and prevention therapies, faster and cheaper.

The current CB agenda covers areas of systems biology, functional genomics, bioinformatics, pattern discovery, medical imaging, computational neuroscience, phylogeny, and more.